The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Nandi is a US-based family office and biotechnology incubator advancing a portfolio of companies focused on rare diseases, oncology, and auto-immune conditions.
Family officeDover, Delaware, United Statesnandilifesciences.comSince 2026-06-10
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Ethyreal Bio Ethyrealbio develops investigational therapies targeting Thyroid Eye Disease and Graves' Disease for patients. | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $101M | 2026-06-10 | [ PART ] |